Sinem Nihal Esatoglu Selected Research

Sinem Nihal Esatoglu Research Topics

3	Uveitis 11/2023 - 11/2017
2	Inflammation (Inflammations) 11/2019 - 11/2018
2	Venous Thrombosis (Deep-Vein Thrombosis) 11/2019 - 12/2018
1	Systemic Scleroderma (Systemic Sclerosis) 02/2024
1	Neoplasms (Cancer) 11/2023
1	Infertility (Sterility) 11/2023
1	Communicable Diseases (Infectious Diseases) 12/2022
1	Tuberculosis (Tuberculoses) 01/2022
1	Latent Tuberculosis 01/2022
1	COVID-19 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Obesity 01/2021
1	Lung Diseases (Lung Disease) 01/2021
1	Pathologic Constriction (Stenosis) 03/2020
1	Crohn Disease (Crohn's Disease) 01/2020
1	Rheumatoid Arthritis 01/2020
1	Ankylosing Spondylitis 01/2020
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2019
1	Aneurysm (Aneurysms) 12/2018
1	Ulcer 11/2018
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 04/2018
1	Vasculitis (Vasculitides) 04/2018
1	Eye Diseases (Eye Disease) 11/2017
1	Proteinuria 08/2017
1	Amyloidosis 08/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2017

2	AA amyloidosisIBA 12/2022 - 08/2017
2	GlucocorticoidsIBA 01/2021 - 12/2018
2	AntibodiesIBA 01/2020 - 12/2018
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 02/2024
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2023
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Antirheumatic Agents (DMARD)IBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 11/2019
1	AnticoagulantsIBA 12/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 11/2018
1	Rituximab (Mabthera)FDA Link 04/2018
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2018
1	Infliximab (Remicade)FDA Link 11/2017
1	Amyloid (Amyloid Fibrils)IBA 08/2017
1	Tumor Necrosis Factor InhibitorsIBA 08/2017

3	Therapeutics 11/2023 - 08/2017
1	Duration of Therapy 11/2023
1	Remission Induction 11/2023
1	Endarterectomy (Thromboendarterectomy) 03/2020